Skip to main content

Table 1 Demographic data, therapeutic intervention modalities and triphasic CT wash-in/out criteria of the studied patients

From: Role of 18F-FDG PET/CT in assessment of HCC patients after therapeutic interventions compared to DW MRI

  Triphasic CT Test value P value Sig.
Negative Positive
No. 12 No. 22
Age
Mean ± SD 61.00 ± 6.81 58.64 ± 12.58 0.602 0.551 NS
Range 52–74 20–77
Sex
Female 3 (25.0%) 8 (36.4%) 0.458* 0.498 NS
Male 9 (75.0%) 14 (63.6%)
Therapeutic intervention
TACE 3 (25.0%) 10 (45.5%) 4.640* 0.326 NS
RFA 6 (50.0%) 7 (31.8%)
Ethanol 0 (0.0%) 3 (13.6%)
Surgery 2 (16.7%) 1 (4.5%)
RFA and ethanol 1 (8.3%) 1 (4.5%)
  1. *Chi-square test; Independent t-test
  2. TACE Trans-arterial chemoembolization, RFA radiofrequency ablation, CT computed tomography